Reunion Neuroscience Inc.
NASDAQ: REUN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gregory T. Mayes
- Employees
- 16
- Headquarters
- Toronto, Canada
- IPO year
- 2020
- Market cap
- $13.1M
- Website
- https://www.fieldtriphealth.com
Loading REUN…
Loading profile data…Frequently asked questions about REUN
What does Reunion Neuroscience Inc. (REUN) do?
Field Trip Health Ltd. is a North American company specializing in the development and delivery of psychedelic-assisted therapies. The organization operates Field Trip Health Centres, which offer psychedelic-based treatments, and provides digital applications under the Field Trip brand. Additionally, its Field Trip Discovery division focuses on...
Where does REUN trade?
Reunion Neuroscience Inc. (REUN) trades on the NASDAQ Global Select.
What sector is REUN in?
Reunion Neuroscience Inc. (REUN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Reunion Neuroscience Inc.?
Gregory T. Mayes is the chief executive officer of Reunion Neuroscience Inc. (REUN).
Where is Reunion Neuroscience Inc. headquartered?
Reunion Neuroscience Inc. is headquartered in Canada.
Does REUN pay a dividend?
Reunion Neuroscience Inc. (REUN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did REUN go public?
Reunion Neuroscience Inc. (REUN) completed its initial public offering in 2020.